+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 25Years - 55Years
All Genders
Healthy Volunteers
ID04390009

Exploratory Evaluation Using Entire-body PET-CT Scans with F18-florbetapir to Assess Demyelination in Multiple Sclerosis

Led by Brain Health Alliance · Updated on 2026-10-06

20

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of entire-body positron emission tomography PET scanners to improve the evaluation, monitoring, and measurement of both peripheral and central demyelination in patients with multiple sclerosis MS. This early phase 1 clinical trial focuses on comparing the uptake of the F18-florbetapir radiopharmaceutical in the nervous system of MS patients versus normal healthy subjects. The study aims to identify differences in radiotracer activity in myelinated, demyelinated, or remyelinated white matter using advanced PET-CT imaging technology. Participants will undergo entire-body PET-CT scans using state-of-the-art scanners from different manufacturers, including Siemens Biograph Vision and United Imaging uEXPLORER, among others. Amyvid F18-florbetapir will be administered to evaluate its binding in the white matter of the peripheral and central nervous system. The study includes parallel arms defined by the specific PET-CT scanner model used. Each participant completes a single PET-CT scan lasting between 10 and 20 minutes. During the study, psychological health will be monitored through questionnaires completed before and up to 90 days after participants are informed of their imaging results, if they choose to receive this information. Researchers will assess the primary outcome of entire-body PET imaging related to demyelination in the nervous system and monitor psychological health changes. The total participation involves a one-day imaging procedure with follow-up psychometric assessments over three months.

CONDITIONS

Brief Title

Entire-body PET Scans for Multiple Sclerosis

Research Team

C

Carl Taswell, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here